A detailed history of Timelo Investment Management Inc. transactions in Profound Medical Corp. stock. As of the latest transaction made, Timelo Investment Management Inc. holds 751,807 shares of PROF stock, worth $5.65 Million. This represents 3.75% of its overall portfolio holdings.

Number of Shares
751,807
Previous 725,895 3.57%
Holding current value
$5.65 Million
Previous $6.09 Million 1.74%
% of portfolio
3.75%
Previous 3.53%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.47 - $11.18 $193,562 - $289,696
25,912 Added 3.57%
751,807 $5.98 Million
Q2 2024

Aug 13, 2024

SELL
$7.25 - $9.07 $942,144 - $1.18 Million
-129,951 Reduced 15.18%
725,895 $6.09 Million
Q1 2024

May 13, 2024

BUY
$7.3 - $9.46 $1.78 Million - $2.31 Million
244,088 Added 39.9%
855,846 $7.3 Million
Q4 2023

Feb 13, 2024

SELL
$7.85 - $11.18 $481,990 - $686,452
-61,400 Reduced 9.12%
611,758 $5.19 Million
Q3 2023

Nov 13, 2023

SELL
$7.91 - $13.27 $462,735 - $776,295
-58,500 Reduced 8.0%
673,158 $6.87 Million
Q2 2023

Aug 10, 2023

SELL
$9.27 - $14.88 $227,309 - $364,872
-24,521 Reduced 3.24%
731,658 $9.52 Million
Q1 2023

May 11, 2023

BUY
$8.85 - $13.27 $792,960 - $1.19 Million
89,600 Added 13.44%
756,179 $7.02 Million
Q4 2022

Feb 10, 2023

BUY
$3.18 - $10.91 $90,948 - $312,026
28,600 Added 4.48%
666,579 $7.26 Million
Q3 2022

Nov 09, 2022

SELL
$3.99 - $9.3 $814,362 - $1.9 Million
-204,101 Reduced 24.24%
637,979 $2.58 Million
Q2 2022

Aug 01, 2022

BUY
$6.34 - $9.53 $407,345 - $612,302
64,250 Added 8.26%
842,080 $6.14 Million
Q1 2022

May 10, 2022

SELL
$8.16 - $11.33 $959,616 - $1.33 Million
-117,600 Reduced 13.13%
777,830 $7 Million
Q4 2021

Feb 10, 2022

BUY
$10.38 - $15.2 $9.29 Million - $13.6 Million
895,430 New
895,430 $10.1 Million

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Timelo Investment Management Inc. Portfolio

Follow Timelo Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Timelo Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Timelo Investment Management Inc. with notifications on news.